Pilan Capital is poised for growth in China's recovering venture capital market, focusing on innovative healthcare and technology sectors while preparing for significant IPO exits.
Information on the Target
Pilan Capital is a well-established venture capital firm that has successfully navigated through two investment cycles, refining its unique business strategy comprising fundraising, investment, management, and exit avenues. The firm has developed standardized processes and management practices, allowing it to efficiently manage both the front-end investment operations and back-end support functions.
In 2025, Pilan Capital is actively engaging in several projects, with three of its portfolio companies having submitted IPO applications in the second quarter. As the capital market shows signs of recovery, the firm anticipates that its early-stage investments will start to yield returns.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in China
The venture capital industry in China is experiencing a notable resurgence in 2025 following a significant adjustment in the policy and market landscape in 2024. Data indicates that investments in hard tec
Similar Deals
弘毅投资 (Hongyi Investment) → 西安紫光国芯半导体股份有限公司 (Xi'an Unigroup Guoxin Semiconductor Corporation)
2025
磐霖资本
invested in
丹擎医药
in 2025
in a Other VC deal
Disclosed details
Transaction Size: $217M